Company: INKT
Filing Date: 2025-04-18
Form Type: PRE 14A
Source: 0000950170-25-055881
Chunk: 30

Company: MiNK Therapeutics, Inc.
Filing Date: 2025-04-18
Form: PRE 14A
Chunk 30
---
 |     |      | 2,047 |
| Garo Armen, Ph.D. |     |               | 178,631 |     |      |     — |
| Robert Kadlec     |     |               |   4,174 |     |      | 1,228 |
| Peter Behner      |     |               |   7,924 |     |      | 2,098 |
| Barbara Ryan      |     |               |  10,424 |     |      | 2,422 |

(3) Dr. Kadlec joined the Board effective October 30, 2024. In respect of their service on the Board in fiscal year 2024, each of our non-employee directors, other than Dr. Armen, was entitled to receive a $50,000 cash retainer and each member of a committee was entitled to receive the following cash fee, prorated for partial years of service:

| Additional annual cash retainer for Audit Committee Chair               |     | $ | 15,000 |
| Additional annual cash retainer for Audit Committee member              |     | $ |  7,500 |
| Additional annual cash retainer for Compensation Committee Chair        |     | $ | 10,000 |
| Additional annual cash retainer for Compensation Committee member       |     | $ |  6,000 |
| Additional annual cash retainer for Corporate Governance and Nominating 
 Committee Chair                                                         |     | $ |  7,500 |
| Additional annual cash retainer for Corporate Governance and Nominating 
 Committee member                                                        |     | $ |  4,000 |

On October 30, 2024, Dr. Kadlec was granted an option to purchase 4,174 shares of our common stock, which vests as to one-third (1/3) of the underlying shares on each of October 30, 2025, October 30, 2026, and October 30, 2027, generally subject to Dr. Kadlec’s continued service through the applicable vesting date.

<div align='center'>22</div>

OWNERSHIP OF OUR COMMON STOCK Ownership By Management On April 24, 2025, MiNK had [ ] shares of common stock issued and outstanding. The table below shows certain information about the beneficial ownership of MiNK common stock, as of April 24, 2025, by: • each of our directors, • each of our named executive officers, and • all of our